BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 4970726)

  • 1. [Nil nocere. Allergic therapeutic agents side effects due to heterogenic follicle-stimulating hormone (FSH)].
    Keitel W; Gutschmidt HJ; Rosam W
    Munch Med Wochenschr; 1968 Mar; 110(12):707-9. PubMed ID: 4970726
    [No Abstract]   [Full Text] [Related]  

  • 2. Gonadotropin--resistant ovaries in primary amenorrhea.
    Van Campenhout J; Vauclair R; Maraghi K
    Obstet Gynecol; 1972 Jul; 40(1):6-12. PubMed ID: 5044939
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antibody formation in therapy using animal pituitary FSH].
    Groot-Wassink K; Rohde W
    Zentralbl Gynakol; 1971 Feb; 93(9):290-4. PubMed ID: 5168525
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acute abdomen following gonadotropin therapy].
    Groot-Wassink K
    Zentralbl Gynakol; 1970 Apr; 92(15):449-56. PubMed ID: 5516772
    [No Abstract]   [Full Text] [Related]  

  • 5. [Stimulation of ovaries with animal hypophyseal FSH-active gonadotropin].
    Daume E
    Geburtshilfe Frauenheilkd; 1966 May; 26(5):600-3. PubMed ID: 5935256
    [No Abstract]   [Full Text] [Related]  

  • 6. [Indications for FSH therapy].
    Groot-Wassink K
    Zentralbl Gynakol; 1967 Mar; 89(9):291-6. PubMed ID: 5585508
    [No Abstract]   [Full Text] [Related]  

  • 7. [Trials of menopausal gonadotropin (HMG) in prolonged amenorrhea and sterility].
    Tscherne E
    Geburtshilfe Frauenheilkd; 1965 Sep; 25(9):843-54. PubMed ID: 5884678
    [No Abstract]   [Full Text] [Related]  

  • 8. [Side effect of HMG--ovarian enlargement].
    Kobayashi T
    Sanfujinka No Jissai; 1971 Jun; 20(7):709. PubMed ID: 5109075
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunological studies with pig FSH (Folistiman)].
    Junge W; Wilken H
    Endokrinologie; 1965; 48(5):293-7. PubMed ID: 4957501
    [No Abstract]   [Full Text] [Related]  

  • 10. Current trends in the treatment of amenorrhoea with human gonadotrophin.
    Crooke AC; Butt WR; Bertrand PV; Morris R
    Proc R Soc Med; 1967 Jul; 60(7):656-8. PubMed ID: 6026901
    [No Abstract]   [Full Text] [Related]  

  • 11. [Course of pregnancy after ovarian stimulation with gonadotropin].
    Groot-Wassink K
    Zentralbl Gynakol; 1970 Apr; 92(14):417-9. PubMed ID: 5516229
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical trial of human gonadotrophins. 3. Variation in sensitivity between patients and standardisation of treatment.
    Crooke AC; Butt WR; Bertrand PV
    Acta Endocrinol (Copenh); 1966; 53():Suppl 111:3-26. PubMed ID: 5333083
    [No Abstract]   [Full Text] [Related]  

  • 13. [Sterility, Stein and H.M.G: a case report].
    Costes D
    Bull Fed Soc Gynecol Obstet Lang Fr; 1969; 21(5):519-20. PubMed ID: 5386395
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.
    Berkkanoglu M; Isikoglu M; Aydin D; Ozgur K
    Fertil Steril; 2007 Sep; 88(3):665-9. PubMed ID: 17292895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of idiopathic secondary amenorrhoea with single injections of follicle-stimulating hormone and chorionic gonadotrophin.
    Crooke AC; Butt WR; Bertrand PV
    Lancet; 1966 Sep; 2(7462):514-6. PubMed ID: 4161639
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lutein cyst formation of the ovaries with perforation and acute abdomen following HMG-HCG treatment].
    Friedrich F; Gitsch E
    Wien Klin Wochenschr; 1969 May; 81(18):318-20. PubMed ID: 5784062
    [No Abstract]   [Full Text] [Related]  

  • 17. [Release of ovulation].
    Tscherne E
    Wien Klin Wochenschr; 1968 Jun; 80(25):486-90. PubMed ID: 5679746
    [No Abstract]   [Full Text] [Related]  

  • 18. [Results of individually dosed gonadotropin therapy using Insler's cervix index].
    Groot-Wassink K
    Zentralbl Gynakol; 1972 Aug; 94(33):1088-93. PubMed ID: 5079735
    [No Abstract]   [Full Text] [Related]  

  • 19. Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function.
    Barad DH; Weghofer A; Gleicher N
    Obstet Gynecol; 2007 Jun; 109(6):1404-10. PubMed ID: 17540814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioassay of antigonadotrophic sera. 3. Assay of the human follicle stimulating hormone (FSH) neutralising potency.
    Robyn C; Diczfalusy E
    Acta Endocrinol (Copenh); 1968 Oct; 59(2):277-97. PubMed ID: 5754973
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.